Transform how you analyse drug development risk
With the only transparent analysis of drug development risk at the product level.
Thought Leadership
Latest Report
Report library
EvaluatePharma Orphan Drug Report 2018
Report Highlights Worldwide orphan drug sales are forecasted to grow at a CAGR of 11% from 2018-2024 The mean price of the top 100 USA orphan drugs is expected to…
ASCO: Skirmishes Break Out In The Great Lung Cancer Battle
Report Highlights For prescribers, at least, it is becoming ever more important to stay up to date with the numerous subgroups into which first-line NSCLC is being…
EP Vantage Pharma, Biotech and Medtech 2017 In Review
Report Highlights All major healthcare indices climbed in 2017, echoing wider stock market strength The $80bn spent on pharma & biotech acquisitions in 2017 makes…
EP Vantage 2018 Preview
Report Highlights M&A activity expected to climb after slow 2017 – US tax reform a deciding factor for big deals Another big year predicted for venture financing…
Evaluate Forecasting Excellence: The Value of Outliers in Consensus Forecasting
Key Report Themes Upside/downside radio metrics that identify companies that could either outperform in the coming years or are at risk Companies that could follow a…
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.